1. Home
  2. LTRN vs BMRA Comparison

LTRN vs BMRA Comparison

Compare LTRN & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

N/A

Current Price

$0.29

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$1.09

Market Cap

8.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LTRN
BMRA
Founded
2013
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
8.5M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
LTRN
BMRA
Price
$0.29
$1.09
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $17.50
N/A
AVG Volume (30 Days)
★ 166.9K
8.8K
Earning Date
11-17-2026
10-15-2026
Dividend Yield
N/A
N/A
EPS Growth
18.65
★ 39.81
EPS
N/A
★ N/A
Revenue
N/A
★ $4,453,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.36
$1.01
52 Week High
$4.34
$2.94

Technical Indicators

Market Signals
Indicator
LTRN
BMRA
Relative Strength Index (RSI) 20.94 22.63
Support Level N/A N/A
Resistance Level $0.84 $1.75
Average True Range (ATR) 0.08 0.15
MACD -0.00 -0.04
Stochastic Oscillator 0.07 11.54

Price Performance

Historical Comparison
LTRN
BMRA

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.

Share on Social Networks: